Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - AcademicCME

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

Cardiometabolic

LIVE UPDATE FROM AHA24: What do we know about antiplatelets added to anticoagulation in pa...

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeuti...

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients wi...